Anthocyanin suppresses the toxicity of Aβ deposits through diversion of molecular forms in in vitro and in vivo models of Alzheimer's disease

References

• Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 1994;13:45–53. doi: 10.1016/0896-6273(94)90458-8
   PubMed Web of Science ®Google Scholar
• Larson J, Lynch G, Games D, Seubert P. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res 1999;840:23–35. doi: 10.1016/S0006-8993(99)01698-4
   PubMed Web of Science ®Google Scholar
• Moechars D, Dewachter I, Lorent K, Reversé D, Baekelandt V, Naidu A, et al. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 1999;274:6483–92. doi: 10.1074/jbc.274.10.6483
   PubMed Web of Science ®Google Scholar
• Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002;416:535–9. doi: 10.1038/416535a
   PubMed Web of Science ®Google Scholar
• Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, et al. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci 2004;24:10191–200. doi: 10.1523/JNEUROSCI.3432-04.2004
   PubMed Web of Science ®Google Scholar
• Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 2007;27:796–807. doi: 10.1523/JNEUROSCI.3501-06.2007
   PubMed Web of Science ®Google Scholar
• Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 2007;27:2866–75. doi: 10.1523/JNEUROSCI.4970-06.2007
   PubMed Web of Science ®Google Scholar
• Dai Q, Borenstein AR, Wu Y, Jackson JC, Larson EB. Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am J Med 2006;119:751–9. doi: 10.1016/j.amjmed.2006.03.045
   PubMed Web of Science ®Google Scholar
• Luchsinger JA, Mayeux R. Dietary factors and Alzheimer's disease. Lancet Neurol 2004;3:579–87. doi: 10.1016/S1474-4422(04)00878-6
   PubMed Web of Science ®Google Scholar
• Joseph JA, Denisova NA, Arendash G, Gordon M, Diamond D, Shukitt-Hale B, et al. Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci 2003;6:153–62. doi: 10.1080/1028415031000111282
   PubMed Web of Science ®Google Scholar
• Wang J, Ho L, Zhao W, Ono K, Rosensweig C, Chen L, et al. Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J Neurosci 2008;28:6388–92. doi: 10.1523/JNEUROSCI.0364-08.2008
   PubMed Web of Science ®Google Scholar
• Rivière C, Delaunay JC, Immel F, Cullin C, Monti JP. The polyphenol piceid destabilizes preformed amyloid fibrils and oligomers in vitro: hypothesis on possible molecular mechanisms. Neurochem Res 2009;34:1120–8. doi: 10.1007/s11064-008-9883-6
   PubMed Web of Science ®Google Scholar
• Vepsäläinen S, Koivisto H, Pekkarinen E, Mäkinen P, Dobson G, McDougall GJ, et al. Anthocyanin-enriched bilberry and blackcurrant extracts modulate amyloid precursor protein processing and alleviate behavioral abnormalities in the APP/PS1 mouse model of Alzheimer's disease. J Nutr Biochem 2013;24:360–70. doi: 10.1016/j.jnutbio.2012.07.006
   PubMed Web of Science ®Google Scholar
• Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004;79:727–47.
   PubMed Web of Science ®Google Scholar
• Rivière C, Richard T, Quentin L, Krisa S, Mérillon JM, Monti JP. Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro. Bioorg Med Chem 2007;15:1160–7. doi: 10.1016/j.bmc.2006.09.069
   PubMed Web of Science ®Google Scholar
• Iwasa H, Kameda H, Fukui N, Yoshida S, Hongo K, Mizobata T, et al. Bilberry anthocyanins neutralize the cytotoxicity of co-chaperonin GroES fibrillation intermediates. Biochemistry 2013;52:9202–11. doi: 10.1021/bi401135j
   PubMed Web of Science ®Google Scholar
• Ichiyanagi T, Kashiwada Y, Ikeshiro Y, Hatano Y, Shida Y, Horie M, et al. Complete assignment of bilberry (Vaccinium myrtillus L.) anthocyanins separated by capillary zone electrophoresis. Chem Pharm Bull (Tokyo) 2004;52:226–9. doi: 10.1248/cpb.52.226
   PubMed Web of Science ®Google Scholar
• Shih PH, Wu CH, Yeh CT, Yen GC. Protective effects of anthocyanins against amyloid β-peptide-induced damage in neuro-2A cells. J Agric Food Chem 2011;59:1683–9. doi: 10.1021/jf103822h
   PubMed Web of Science ®Google Scholar
• Gutierres JM, Carvalho FB, Schetinger MR, Marisco P, Agostinho P, Rodrigues M, et al. Anthocyanins restore behavioral and biochemical changes caused by streptozotocin-induced sporadic dementia of Alzheimer's type. Life Sci 2014;96:7–17. doi: 10.1016/j.lfs.2013.11.014
   PubMed Web of Science ®Google Scholar
• Schägger H. Tricine–SDS–PAGE. Nat Protoc 2006;1:16–22. doi: 10.1038/nprot.2006.4
   PubMed Web of Science ®Google Scholar
• Toda T, Noda Y, Ito G, Maeda M, Shimizu T. Presenilin-2 mutation causes early amyloid accumulation and memory impairment in a transgenic mouse model of Alzheimer's disease. J Biomed Biotechnol 2011;2011:617974. doi: 10.1155/2011/617974
   PubMedGoogle Scholar
• Kishimoto Y, Kirino Y. Presenilin 2 mutation accelerates the onset of impairment in trace eyeblink conditioning in a mouse model of Alzheimer's disease overexpressing human mutant amyloid precursor protein. Neurosci Lett 2013;538:15–9. doi: 10.1016/j.neulet.2013.01.025
   PubMed Web of Science ®Google Scholar
• Sakakibara H, Ogawa T, Koyanagi A, Kobayashi S, Goda T, Kumazawa S, et al. Distribution and excretion of bilberry anthocyanins [corrected] in mice. J Agric Food Chem 2009;57:7681–6. doi: 10.1021/jf901341b
   PubMed Web of Science ®Google Scholar
• Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008;14:837–42. doi: 10.1038/nm1782
   PubMed Web of Science ®Google Scholar
• Ahmad E, Ahmad A, Singh S, Arshad M, Khan AH, Khan RH. A mechanistic approach for islet amyloid polypeptide aggregation to develop anti-amyloidogenic agents for type-2 diabetes. Biochimie 2011;93:793–805. doi: 10.1016/j.biochi.2010.12.012
   PubMed Web of Science ®Google Scholar
• Cheng B, Gong H, Xiao H, Petersen RB, Zheng L, Huang K. Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases. Biochim Biophys Acta 2013;1830:4860–71. doi: 10.1016/j.bbagen.2013.06.029
   PubMed Web of Science ®Google Scholar
• Sato M, Murakami K, Uno M, Nakagawa Y, Katayama S, Akagi K, et al. Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues. J Biol Chem 2013;288:23212–24. doi: 10.1074/jbc.M113.464222
   PubMed Web of Science ®Google Scholar
• Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 2008;15:558–66. doi: 10.1038/nsmb.1437
   PubMed Web of Science ®Google Scholar
• Vingtdeux V, Giliberto L, Zhao H, Chandakkar P, Wu Q, Simon JE, et al. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J Biol Chem 2010;285:9100–13. doi: 10.1074/jbc.M109.060061
   PubMed Web of Science ®Google Scholar
• Wang J, Bi W, Cheng A, Freire D, Vempati P, Zhao W, et al. Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer's disease-experimental approach and therapeutic implications. Front Aging Neurosci 2014;6:42.
   PubMed Web of Science ®Google Scholar
• Grossi C, Rigacci S, Ambrosini S, Dami TE, Luccarini I, Traini C, et al. The polyphenol oleuropein aglycone protects TgCRND8 mice against Aβ plaque pathology. PLoS One 2013;8:e71702. doi: 10.1371/journal.pone.0071702
   PubMed Web of Science ®Google Scholar
• Tarozzi A, Morroni F, Hrelia S, Angeloni C, Marchesi A, Cantelli-Forti G, et al. Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells. Neurosci Lett 2007;424:36–40. doi: 10.1016/j.neulet.2007.07.017
   PubMed Web of Science ®Google Scholar
• Poulose SM, Fisher DR, Larson J, Bielinski DF, Rimando AM, Carey AN, et al. Anthocyanin-rich açai (Euterpe oleracea Mart.) fruit pulp fractions attenuate inflammatory stress signaling in mouse brain BV-2 microglial cells. J Agric Food Chem 2012;60:1084–93. doi: 10.1021/jf203989k
   PubMed Web of Science ®Google Scholar
• Renis M, Calandra L, Scifo C, Tomasello B, Cardile V, Vanella L, et al. Response of cell cycle/stress-related protein expression and DNA damage upon treatment of CaCO2 cells with anthocyanins. Br J Nutr 2008;100:27–35. doi: 10.1017/S0007114507876239
   PubMed Web of Science ®Google Scholar
• Martín-Moreno AM, Brera B, Spuch C, Carro E, García-García L, Delgado M, et al. Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice. J Neuroinflammation 2012;9:8. doi: 10.1186/1742-2094-9-8
   PubMed Web of Science ®Google Scholar